Low- and medium-dose diltiazem in chronic atrial fibrillation: Comparison with digoxin and correlation with drug plasma levels

American Heart Journal

Volumn 116, Issue 2 PART 1, 1988, Pages 385-392

  Maragno, Ildebrando ^a   Santostasi, Giovanni ^a   Gaion, Rosa M ^a   Trento, Massimo ^a   Grion, Anna M ^a   Miraglia, Giuseppe ^a   Volta, Sergio Dalla ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; DILTIAZEM;

ADULT; AGED; ASTHENIA; BLOOD PRESSURE; CLINICAL ARTICLE; DYSPNEA; HEART ATRIUM FIBRILLATION; HEART RATE; HEARTBURN; HOLTER MONITORING; HUMAN; LEG EDEMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; ATRIAL FIBRILLATION; BLOOD PRESSURE; CHRONIC DISEASE; COMPARATIVE STUDY; DIGOXIN; DILTIAZEM; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; EXERTION; FEMALE; HEART RATE; HUMAN; MALE; MIDDLE AGE;

EID: 0023679887     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(88)90610-2     Document Type: Article

References (37)

1. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes
2. Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue
3. Beneficial effect of intravenous diltiazem in the acute management of paroxysmal supraventricular tachyarrhythmias
4. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia
5. Effect of calcium antagonist diltiazem on atrioventricular conduction in chronic atrial fibrillation
6. Diltiazem, verapamil and quinidine in patients with chronic atrial fibrillation
7. Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation
8. Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise
9. Diltiazem in the treatment of atrial fibrillation
10. Clinical effects of digoxin on sinus node and atrioventricular node function after pharmacological autonomic blockade
11. Inefficacy of “therapeutic” serum levels of digoxin in controlling the ventricular rate in atrial fibrillation
12. Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation
13. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease
14. Comparative effects of verapamil, diltiazem and nifedipine on hemodynamics and left ventricular function during acute myocardial ischemia in dogs
15. Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure
16. High-dose intravenous diltiazem in man. Hemodynamic and antiischemic effects in impaired vs normal left ventricular function [Abstract]
17. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay
18. La fibrillation auriculaire: quelques problèmes pratiques actuels
19. Intracardiac electrophysiologic study of intravenous diltiazem and combined diltiazem-digoxin in patients
20. Twenty four hour embulatory electrocardiography in patients with chronic atrial fibrillation
21. Pharmacodynamic aspects of intravenous diltiazem administration
22. Verapamil and digoxin: their respective effects on atrial fibrillation and their interaction
23. Effects of diltiazem on atrioventricular conduction and arterial blood pressure: correlation with plasma drug concentrations
24. Relationship between plasma diltiazem and cardiovascular responses in conscious dogs
25. Relationship between diltizem plasma levels and its hemodynamic effects [Abstract]
26. Pharmacokinetic and pharmacodynamic effects of diltiazem
27. Drugs
28. Potentiation of cardiac electrophysiologic effects of verapamil after autonomic blockade or cardiac transplantation
29. Verapamil plasma levels and ventricular rate response in patients with atrial fibrillation and flutter
30. Comparative electrophysiologic effects of bepridil, verapamil and diltiazem in conscious and anesthetized dogs
31. Effects of diltiazem on plasma level and urinary excretion of digoxin in healthy subjects
32. The diltiazemdigoxin interaction
33. Effect of diltiazem on renal clearance and serum concentration of digoxin in patients with cardiac disease
34. Digoxin-diltiazem interaction: a pharmacokinetic evaluation
35. Verapamil in atrial fibrillation: the expected, the unexpected and the unknown
36. The long-term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects
37. Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation